Hosted on MSN

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever

The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...

Pfizer Lyme vaccine shows 70% efficacy, misses trial goal

Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical ...

Pfizer’s weight management drug wins China approval

Pfizer Inc. (NYSE:PFE) is included among the 14 Low PE High Dividend Stocks to Buy Right Now. On March 6, Reuters reported that China has approved Pfizer Inc. (NYSE:PFE)’s GLP-1 treatment Xianweiying ...